Renal Cysts and Nephrocalcinosis in a Patient Deficient in 11 beta-Hydroxylase Enzyme

被引:2
|
作者
Aswani, Yashant [1 ,2 ]
Thakkar, Hemangini [1 ,2 ]
Hira, Priya [1 ,2 ]
机构
[1] King Edward Mem Hosp, Dept Radiol, Mumbai, Maharashtra, India
[2] Seth Gordhandas Sunderdas Med Coll, Mumbai, Maharashtra, India
关键词
Adrenal Hyperplasia; Congenital; Hypertension; Hypokalemia; Nephrocalcinosis;
D O I
10.12659/PJR.894678
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Chronic hypokalemia is known to induce renal structural and functional abnormality. The former includes induction of renal cyst formation and interstitial fibrosis while the latter entails urineconcentrating defect. However, these hypokalemia-mediated changes occur in a handful of conditions including primary aldosteronism, distal renal tubular acidosis, Liddle's disease, apparent mineralocorticoid excess syndrome and Bartter's type 3 syndrome. Such a finding has never been described in an 11 beta-hydroxylase deficient individual. Case Report: We describe a case of a 15-year-old male, deficient in 11 beta-hydroxylase enzyme, presenting with hypertensive haemorrhage in basal ganglia and chronic hypokalemia-mediated nephrocalcinosis and renal cysts. To add to the uniqueness, our patient was discovered to harbour bilateral testicular adrenal rests as well. Conclusions: An early diagnosis could help prevent these sequelae and preserve long-term renal function and safeguard against ill-effects of hypertension. Besides, aetiology of nephrocalcinosis should be sought for and corrected.
引用
收藏
页码:379 / 381
页数:3
相关论文
共 50 条
  • [1] HYPERTENSION IN A NEONATE WITH 11 BETA-HYDROXYLASE DEFICIENCY
    MIMOUNI, M
    KAUFMAN, H
    ROITMAN, A
    MORAG, C
    SADAN, N
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1985, 143 (03) : 231 - 233
  • [2] SERUM DOPAMINE BETA-HYDROXYLASE - ASSAY AND ENZYME PROPERTIES
    MARKIANOS, ES
    NYSTROM, IE
    [J]. ZEITSCHRIFT FUR KLINISCHE CHEMIE UND KLINISCHE BIOCHEMIE, 1975, 13 (07): : 273 - 276
  • [3] AN 11 BETA-HYDROXYLASE INHIBITOR IN THE TREATMENT OF RESISTANT ASCITES
    SHALDON, S
    MCLAREN, JR
    [J]. LANCET, 1960, 2 (DEC17): : 1330 - 1332
  • [4] Impairment of 11 beta-hydroxylase but not 21-hydroxylase in adrenal 'incidentalomas'
    Reincke, M
    Peter, M
    Sippell, WG
    Allolio, B
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 136 (02) : 196 - 200
  • [5] STRUCTURE-ACTIVITY STUDY OF 11 BETA-HYDROXYLASE INHIBITORS
    HAYS, SJ
    GILDERSLEEVE, DL
    BROWN, LE
    TOBES, MC
    WIELAND, DM
    BEIERWALTES, WH
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1981, 22 (06) : P58 - P58
  • [6] Renal cysts and nephrocalcinosis in a patient with Bartter syndrome type III
    Watanabe, T
    Tajima, T
    [J]. PEDIATRIC NEPHROLOGY, 2005, 20 (05) : 676 - 678
  • [7] Renal cysts and nephrocalcinosis in a patient with Bartter syndrome type III
    Toru Watanabe
    Toshihiro Tajima
    [J]. Pediatric Nephrology, 2005, 20 : 676 - 678
  • [8] Altered 11 beta-hydroxylase activity in glucocorticoid-suppressible hyperaldosteronism
    Jamieson, A
    Ingram, MC
    Inglis, GC
    Davies, E
    Fraser, R
    Connell, JMC
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06): : 2298 - 2302
  • [9] Height augmentation in 11 beta-hydroxylase deficiency congenital adrenal hyperplasia
    Nour, Munier A.
    Pacaud, Daniele
    [J]. INTERNATIONAL JOURNAL OF PEDIATRIC ENDOCRINOLOGY, 2015,
  • [10] ELEVATED PLASMA DEHYDROEPIANDROSTERONE DHA IN MILD 11 BETA-HYDROXYLASE DEFICIENCY
    WERDER, EA
    TASSINARI, D
    ZACHMANN, M
    [J]. PEDIATRIC RESEARCH, 1982, 16 (10) : 895 - 895